Key Points HUN shares look overly discounted as MDI fundamentals bottom; supply may tighten on delays, Middle East disruption risk, and Wanhua’s exclusion from the U.S. MDI operating rates normalizing to 87–88%...
Key Points Q4’25 EBITDA beat but EPS miss. Q1’26 guidance below consensus EBITDA contraction observed across all three segments (y-o-y). Management commentary cautious We rate HUN shares Overweight with a 12-month target price...
Key Points Q3’25 earnings beat but Q4’25 guidance below consensus. Dividend cut 65% EBITDA contraction observed across all three segments (y-o-y). Management commentary cautious We rate HUN shares Overweight with a 12-month target...
Key Points Periods of extreme MDI demand weakness, similar to the last three years, typically followed by strong demand rebounds MDI cycle could normalize as early as 2026/2027 with significant earnings and...
Key Points Q2’25 EBITDA miss; midpoint of Q3'25 guidance range below consensus EBITDA contraction observed across all three segments (y-o-y). Management commentary cautious We rate HUN shares Overweight with a 12-month target price...
Key Points Periods of extreme MDI demand weakness, similar to the last three years, typically followed by strong demand rebounds MDI cycle could normalize as early as 2026/2027 with significant earnings and...
Key Points Q1’25 EBITDA miss; midpoint of Q2'25 guidance range below consensus Margin weakness observed across two of three segments (y-o-y). Polyurethane margins and volumes up y-o-y in Q1. Management commentary cautious We...